Technical Analysis for AVCTF - Avacta Group Plc

Grade Last Price % Change Price Change
C 1.5000 20.00% 0.2500
AVCTF closed up 20.0 percent on Friday, May 26, 2023, on 58 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Hot IPO Pullback Bullish Swing Setup 20.00%
Narrow Range Bar Range Contraction 20.00%
New 52 Week Closing Low Bearish 20.00%
Narrow Range Bar Range Contraction 20.00%
New 52 Week Low Weakness 20.00%
Gapped Down Weakness 20.00%
Narrow Range Bar Range Contraction -26.83%
Gapped Up Strength -26.83%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Avacta Group Plc Description

Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Biopharmaceutical Life Sciences Stem Cells Autoimmune Diseases Alpha Stage Biopharmaceutical Immunotherapies Drug Development Cancer Therapies Novel Cancer Party Products

Is AVCTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.29
52 Week Low 1.25
Average Volume 1,216
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 1.8060
Average True Range 0.0000
RSI (14) 0.00
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line -0.0252
MACD Signal Line -0.0050
MACD Histogram -0.0201
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.5000
Resistance 3 (R3) 1.5000 1.5000 1.5000
Resistance 2 (R2) 1.5000 1.5000 1.5000 1.5000
Resistance 1 (R1) 1.5000 1.5000 1.5000 1.5000 1.5000
Pivot Point 1.5000 1.5000 1.5000 1.5000 1.5000
Support 1 (S1) 1.5000 1.5000 1.5000 1.5000 1.5000
Support 2 (S2) 1.5000 1.5000 1.5000 1.5000
Support 3 (S3) 1.5000 1.5000 1.5000
Support 4 (S4) 1.5000